Immatics (IMTX) Research & Development (2019 - 2026)
Immatics' Research & Development was $72.54 million in Q2 2026, up 42.1% from $51.06 million a year earlier and up 4.7% from the prior quarter.
Powered by 
Analysis
Immatics (IMTX) Research & Development (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immatics' Research & Development was $254.77 million through Jun 30, 2026, up 39.5% year-over-year; for FY2025, it came in at $207.7 million, up 29.6% from FY2024.
- Research & Development has now increased for seven consecutive years, with a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
- In earlier years, Research & Development was $160.27 million in FY2024 (+24.9%), $128.36 million in FY2023 (+14.1%), $112.54 million in FY2022 (+8.6%) and $103.63 million in FY2021 (+35.3%).
- The Q2 2026 figure marks the highest quarterly Research & Development in data going back to Q2 2019.
- Compared with a year earlier, Research & Development has increased for 25 straight quarters, with growth averaging 34.0% over the last eight quarters.
- The year-over-year growth in Research & Development has ranged between 1.5% (Q1 2022) and 57.2% (Q1 2026) over the last five years.
- Per Business Quant data, IMTX's Research & Development in the three quarters before Q2 2026 was $69.29 million (Q1 2026), $57.79 million (Q4 2025) and $55.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Immatics | 809.95 Mn | -1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.54 Mn |
| Mar 31, 2026 | 69.29 Mn |
| Dec 31, 2025 | 57.79 Mn |
| Sep 30, 2025 | 55.15 Mn |
| Jun 30, 2025 | 51.06 Mn |
| Mar 31, 2025 | 44.08 Mn |
| Dec 31, 2024 | 44.72 Mn |
| Sep 30, 2024 | 42.73 Mn |
| Jun 30, 2024 | 37.92 Mn |
| Mar 31, 2024 | 34.88 Mn |
| Dec 31, 2023 | 35.79 Mn |
| Sep 30, 2023 | 33.20 Mn |
| Jun 30, 2023 | 29.75 Mn |
| Mar 31, 2023 | 29.60 Mn |
| Dec 31, 2022 | 28.41 Mn |
| Sep 30, 2022 | 28.81 Mn |
| Jun 30, 2022 | 26.91 Mn |
| Mar 31, 2022 | 28.22 Mn |
| Dec 31, 2021 | 26.27 Mn |
| Sep 30, 2021 | 25.03 Mn |
API Access
Immatics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();